NDRC Releases Drug Pricing Reform Roadmap: From Price Caps To Prices
This article was originally published in PharmAsia News
Executive Summary
China’s National Development and Reform Commission has issued a roadmap for medical and pharma pricing reforms, covering patent-off drugs, generics and medical devices which proposes allowing market-determined pricing where appropriate.